Union Drilling, Inc. (NASDAQ:UDRL) announced that it will release its 2011 second quarter results after the market closes on Wednesday, August 3, 2011. In conjunction with the release, the Company has scheduled a conference call which will be broadcast live over the Internet on Thursday, August 4, 2011 at 10:00 a.m. Eastern time. Union Drilling Second Quarter 2011 Earnings Conference Call Thursday, August 4, 2011 at 10:00 a.m. Eastern time, Live via phone - By dialing 480-629-9818 or live over the Internet by logging onto the web at the address, www.uniondrilling.com.
Union Drilling, Inc. provides contract land drilling services and equipment primarily to independent natural gas producers in the United States.
Blue Gold Beverages, Inc. (BGBV)
Blue Gold Beverages, Inc. (PINK SHEETS:BGBV) is pleased to announce it has signed a definitive agreement to acquire 100% of the shares of Epic Nutrition, Inc. a manufacturer and distributor of their own proprietary brands Quick NRG Energy Shot™, Goodnight™ (Sleep & Relaxation Supplement), NRG Pro-N-Go™ (Protein Energy Shot) and COLDsense™ natural cold and flu remedy.
"The addition of Epic Nutrition, Inc. as a wholly owned subsidiary of Blue Gold Beverages, Inc. provides us with a solid marketing platform from which to grow our specialty beverage business in North America" comments Mr. Larry Latowsky, the recently appointed Chairman of the Board of Blue Gold Beverages, Inc. "Epic Nutrition, Inc. is a company I know very well and has developed several new proprietary products that we intend to also market through the Canadian distribution channels already acquired by Blue Gold Beverages from Epic Canada.
With the introduction of these new products, and through a new sales agreement with major US broker, combined with our new distribution agreement for PitBull Energy Bars we anticipate revenues to reach in excess of $20 million dollars by the end of 2012."
Energy drinks refer to beverages that contain, besides calories, caffeine in combination with other presumed energy-enhancing ingredients such as taurine, herbal extracts, and B vitamins. Energy drinks fall into the category of functional and include ready-to-drink (RTD), shots, and in powder form. Globally, energy drinks hold 47.3% of the functional beverage's overall market share, while in the United States they comprise 62.6% (Datamonitor 2008a, 2008b). Energy drinks in particular have experienced impressive growth of more than 240% in the United States, as well as abroad, from 2004 to 2009 (Mintel 2009. The U.S. energy drink industry is anticipated to more than double and reaches an astounding $19.7 billion in 2013, which is almost a 160% increase from 2008 . Within the functional beverage category, the energy drink segment has experienced the largest volume growth and increased annual sales, both in the United States and abroad, reaching $4.8 billion in 2008 in the United States alone
For more information BGBV, please visit: http://www.bluegoldbeverages.com
Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY) announced new findings published in Nature (Baughman et al., Nature advance online publication 19 June 2011; doi: 10.1038/nature10234). Using an "integrative genomics" strategy that included RNAi technology, the study identified for the first time the mitochondrial calcium uniporter (MCU), which regulates calcium transport into mitochondria. This new discovery now enables molecular studies on mitochondrial calcium physiology with implications for advancement of new medicines across a broad range of diseases.
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics based on RNA interference (RNAi).
POWER 3 MEDICAL PROD (PWRM)
Breast cancer is the second most common cancer among women, with about 192,000 new cases each year. Breast cancer remains the leading cause of death of women between ages 40 and 55. Current treatments for women with breast cancer include surgery, radiation therapy, chemotherapy and hormonal therapy. Treatment methods are classified as local or systemic. Systemic treatments, such as chemotherapy and hormonal therapy, destroy or control cancer cells throughout the body. Depending on your condition, you may receive a single treatment or a combination of therapies given at the same time or in succession.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases.
Power 3 Medical Products' BC-SeraPro is a blood serum test designed to diagnose breast cancer in individuals. The test is based on proteomic technology in which a blood serum sample drawn from a patient will monitor the concentration of each protein biomarker residing in a panel of blood serum protein biomarkers to determine if a patient has breast cancer. The biomarkers in the panel have been selected for their ability to discriminate breast cancer patients from non-cancerous patients.
For more information please visit official website of PWRM:http://www.power3medical.com.
CE Franklin Ltd. (NASDAQ:CFK) announced that Mr. Dharmesh Prasad, Global Materials Manager of Schlumberger Limited ("Schlumberger"), CE Franklin's majority shareholder, was appointed today as the new Schlumberger representative to the Board of Directors of CE Franklin. Mr. Prasad replaces Kjell-Erik Oestdahl who has stepped down from our Board due to time commitments and expanded responsibilities in connection with his recent promotion as Vice-President, Operations of Schlumberger.
CE Franklin Ltd. distributes oilfield equipment products and services principally to the oil and gas industry in western Canada.
CRWESelect, a stock highlight publication is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter at http://www.crweselect.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB). Crown Equity Holdings Inc. (CRWE.OB) has received seven thousand five hundred dollars ($7,500) in cash from a third party (9186 2780 Quebec Inc) for 1 week of media advertisement services for Blue Gold Beverages, Inc. (BGBV).